20896 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tripeptides
Sub-classes:COMPOSITIONS AND METHODS FOR TREATING AGING-RELATED METABOLIC AND NEUROLOGICAL DISORDERS
#2ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#3PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
#4PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#5Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis
#6METHODS AND COMPOSITIONS FOR DETECTING AND DIAGNOSING DISEASES AND CONDITIONS
#7METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME
#8SYNERGISTIC COMBINATION OF NAD+ AND THERAPEUTIC PEPTIDES DELIVERED VIA IONTOPHORESIS FOR ENHANCED AND PROLONGED REGENERATIVE EFFECTS
#9METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS
#10PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#11NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEIN
#12PEPTIDE HAVING ACE INHIBITORY ACTIVITY AND COMPOSITION CONTAINING THE SAME
#13TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#14COMPOSITIONS AND METHODS FOR HAIR TREATMENT
#15HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION
#16METHODS OF TREATING GLIOBLASTOMA WITH PRODRUGS OF RILUZOLE
#17PEPTIDE-IONIC LIQUID CONJUGATE FOR THE PREVENTION AND/OR TREATMENT OF SKIN DISORDERS
#18SYNERGISTIC COMBINATION OF NAD+ AND THERAPEUTIC PEPTIDES DELIVERED VIA IONTOPHORESIS FOR ENHANCED AND PROLONGED REGENERATIVE EFFECTS
#19COMPOSITION FOR SUPPRESSING HAIR LOSS OR PROMOTING HAIR GROWTH CONTAINING PEPTIDE
#20RILUZOLE PRODRUGS AND THEIR USE
#21TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
#22METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#23AFFINITY ILLUDOFULVENE CONJUGATES
#24DYSREGULATION OF NEUROPROTEASOMES BY APOE ISOFORMS DRIVES ENDOGENOUS TAU AGGREGATION
#25COMPOSITIONS AND METHODS FOR HAIR TREATMENT
#26PRODRUGS AS SELECTIVE ANTIBIOTICS AGAINST COLIBACTIN-PRODUCING E. COLI
#27METHODS FOR REDUCING CD36 EXPRESSION
#28FLUOROCHEMICAL TARGETED THERAPIES
#29METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#30Methods and Compositions for Inhibiting Viral Infection
#31METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#32TOPICAL COMPOSITION AND USES THEREOF
#33PHARMACEUTICAL COMPOSITION COMPRISING THROMBOLYTIC PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATE
#34PEPTIDE REGULATORS OF METABOLISM
#35CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#36COMPOSITION FOR PROMOTING HAIR GROWTH, PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH COMPRISING THE COMPOSITION, AND METHOD FOR PROMOTING HAIR GROWTH BY USING THE SAME
#37TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS
#38AMINO ACID COMPOSITIONS AND METHODS OF MANUFACTURING THE COMPOSITIONS
#39METHODS FOR EVALUATION AND TREATMENT OF TYROSINE KINASE INHIBITOR (TKI)-RESISTANT ACUTE MYELOID LEUKEMIA
#40COMPOSITIONS AND METHODS RELATING TO PEDIATRIC NEUROMUSCULAR DISEASES AND NEUROGENERATIVE DISORDERS
#41METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#42ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES
#43METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF MUSCULAR DYSTROPHY
#44CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES
#45BIFUNCTIONAL COMPOSITIONS FOR THE TREATMENT OF CANCER
#46COMBINATION OF OCTAPEPTIDE AND HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR TOPICAL APPLICATION
#47OCTAPEPTIDE FOR TOPICAL APPLICATION
#48PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
#49AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#50Compositions and Methods for Enhanced Aquatic Farming and Aquarium Fish Husbandry
#51MODIFIED TRIPEPTIDES FOR USE IN THE TREATMENT OF A NON-ENVELOPED VIRUS INFECTION
#52PEPTIDES WITH ANTI-ANGIOGENIC ACTIVITY
#53OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
#54COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF VASCULAR MALFORMATIONS
#55COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#56PEPTIDE HAVING OBESITY AND MUSCLE LOSS INHIBITORY ACTIVITIES, AND USE THEREOF
#57COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION
#58PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF
#59COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION
#60COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION
#61Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
#62TOPICAL COMPOSITIONS
#63NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#64PEPTIDE HAVING ANTICANCER ACTIVITY, AND USE THEREOF
#65DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE
#66COMPOSITION FOR RESPIRATORY DISEASES
#67TOPICAL AND PARENTERAL USE AND ADMINISTRATION OF SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS
#68METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE
#69ANTI-OBESITY PEPTIDES AND USES THEREOF
#70COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INSULIN RESISTANCE AND METABOLIC CONDITIONS
#71DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#72ACETYL SH-HEXAPEPTIDE-5 AMIDE ACETATE FOR USE IN THE TREATMENT OF HAIR LOSS DISORDERS AND AS A HAIR CARE AGENT
#73BRUISING AND FILLER COMPOSITIONS AND METHODS FOR USE
#74COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS USEFUL IN TUMOR THERAPY
#75CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO
#76CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
#77COMPOUNDS FOR USE IN THE TREATMENT OF AN ENVELOPED VIRUS INFECTION
#78Methods and compositions for the prevention or treatment of Barth Syndrome
#79COMPOUNDS FOR USE IN THE TREATMENT OF SINUSITIS, PNEUMONIA OR OTITIS
#80SMALL MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF ALS AND RELATED DISORDERS
#81COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN
#82TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#83CARDIOVASCULAR DISEASE MEDICATION ADMINISTRATION METHODS
#84Methods for Treating HCV
#85PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#86USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE
#87TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
#88REPOSITIONING THE ANTI-LEPROSY DRUG CLOFAZIMINE AGAINST DRUG-RESISTANT MYELOMA AND PUTATIVE STEM-CELL SUBCLONES
#89IMMUNOSTIMULATORY METHOD
#90AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES
#91N-f-MLF DERIVATIVES THAT INHIBIT FORMYL PEPTIDE RECEPTORS FOR THE TREATMENT OF DISEASE
#92METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#93Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate
#94COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE
#95USE OF PEPTIDES AS THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES
#96COMPOUNDS FOR TREATING ENVELOPED VIRUS INFECTIONS
#97COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES
#98TREATMENT OF DERMATOLOGICAL CONDITIONS
#99GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
#100INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#101Skin care formulation containing silver nanoparticles
#102METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#103COMPOSITIONS AND METHODS RELATING TO ALOPECIA
#104Cytotoxic and anti-mitotic compounds, and methods of using the same
#105Methods and compositions for preventing or treating ophthalmic conditions
#106RILUZOLE PRODRUGS AND THEIR USE
#107Riluzole prodrugs and their use
#108METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION
#109DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS
#110NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#111Compositions and methods for improving bruising and rejuvenating skin
#112METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#113MEDICAL DEVICES AND MATERIALS COMPRISING BIODEGRADABLE POLYESTERS
#114COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN CONFORMATIONAL DISORDER
#115COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE
#116N-ACYL AMINO ACID PRODUCTS AND USES
#117COMPOSITION, USE OF THE COMPOSITION, COSMETIC METHOD FOR MODULATING THE PRODUCTION OF SEBUM
#118Cytotoxic and anti-mitotic compounds, and methods of using the same
#119BONE-PROMOTING THERMORESPONSIVE MACROMOLECULES
#120NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#121METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#122Compositions and Methods for Treating Granulomatosis with Polyangiitis
#123Pharmaceutical combinations for treating cancer
#124IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
#125PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#126PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#127PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#128Cysteine protease inhibitors and methods of use thereof
#129EFFECTIVE TREATMENTS FOR VASCULAR ASSOCIATED MACULOPATHY, SEVERE MACULOPATHY, LATE-STAGE MACULOPATHY, AND ABERRANT CHORIOCAPILLARIS
#130A SYNERGISTIC FORMULATION FOR MANAGEMENT OF RESPIRATORY PATHOGENS INCLUDING CORONAVIRUSES
#131COMPATIBLE SOLUTES FOR PREVENTING OR TREATING SARS-COV-2 INFECTIONS
#132METHODS FOR REDUCING CD36 EXPRESSION
#133Affinity illudofulvene conjugates
#134NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#135METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#136METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS
#137TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS
#138COMPOSITIONS AND METHODS TO TREAT POLYCYSTIC KIDNEY DISEASE
#139USE OF A COMPOUND OR COMPOSITION COMPRISING AN INHIBITOR OF NLRP1 INFLAMMASOME ACTIVATION FOR THE TREATMENT OF HUMAN AIRWAY INFLAMMATION
#140COMPOSITIONS AND METHOD OF MODULATING GROWTH FACTOR FUNCTION
#141NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#142SMALL MOLECULE INHIBITORS OF SARS-CoV-2 VIRAL REPLICATION AND USES THEREOF
#143Compositions and methods for the treatment and prevention of vascular malformations
#144Tripeptide propylene oxide derivative and preparation method and application thereof
#145METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
#146MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#147MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#148Amino acid compositions and methods of manufacturing the compositions
#149DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF FOR FAT LOSS
#150NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#151Cosmetic compositions
#152Topical copper tripeptide composition
#153NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#154NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#155TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN COMBINATION THERAPY
#156NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#157MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY
#158ANTIOXIDANT POLYMERIC BIOMATERIAL FOR TISSUE ENGINEERING AND METHODS OF USING SAME
#159ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS
#160COMPOUNDS FOR TREATING BRAIN CANCER
#161COMPOSITIONS AND METHODS INVOLVING AMINO ACIDS FOR THE TREATMENT OF FAT INFILTRATIONS IN MUSCLE
#162METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE
#163DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES
#164NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEINS
#165Methods and compositions for detecting and diagnosing diseases and conditions
#166PHARMACEUTICAL COMPOSITION COMPRISING PEPTIDE THAT INHIBITS INTERACTION OF P53 AND FOXO4
#167COMPOSITION COMPRISING P53-ACTIVATING PEPTIDE
#168Riluzole prodrugs and their use
#169BRAIN FUNCTION REGULATING AGENT, AND FOOD OR BEVERAGE PRODUCT CONTAINING SAME
#170COMPOSITIONS AND METHODS EXCLUDING OR WITH REDUCED GLUTAMINE FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS
#171Systems Chemico-Pharmacology Drugs and Methods of Use
#172ANTIVIRAL PEPTOID COMPOSITIONS
#173Prodrugs of riluzole and their method of use
#174Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#175COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS
#176PEPTIDE, COMPOSITION, AND METHOD FOR TREATING, PREVENTING, OR AMELIORATING MOOD DISORDER
#177Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate
#178Topical compositions
#179METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMES
#180METHOD FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME USING AN INHIBITORY OR CYTOTOXIC AGENT AGAINST PLASMA CELLS
#181METHODS FOR TREATING COVID-19 BASED ON INDIVIDUAL GENOMIC PROFILES
#182HAIR GROWING AGENT AND FOOD OR BEVERAGE PRODUCT COMPRISING SAME
#183METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#184Immunostimulatory method
#185Methods for Treating HCV
#186METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#187Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#188CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY
#189Peptidomimetics for the treatment of coronavirus and picorna virus infections
#190CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#191Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#192INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#193MUSCLE QUALITY IMPROVEMENT AGENT
#194Conjugates of quaternized tubulysin compounds
#195Composition and Concentrate for Use in Preparation of Dialysis Solution, Corresponding Dialysis Solution and Combinations Comprising Container
#196Peptides and combination of peptides for use in immunotherapy against various tumors
#197Inhibitors of IAP
#198Compositions, delivery systems, and methods useful in tumor therapy
#199METHODS AND COMPOSITIONS FOR TRANSGENE EXPRESSION
#200AGING PROGRESSION SUPPRESSING AGENT, AND FOOD OR BEVERAGE PRODUCT COMPRISING SAME
#201METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES
#202Fluorochemical targeted therapies
#203Peptide having antioxidant activity and composition containing same
#204Inhibitors for proliferating cell nuclear antigen and uses
#205PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S)
#206PAR2 MODULATION AND METHODS THEREOF
#207COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#208METHOD OF USING COMPOSITION FOR TREATMENT OF VEISALGIA
#209SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS
#210SYSTEMS AND METHODS FOR CHARACTERIZING AND TREATING DISEASE
#211COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES
#212NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#213BRAIN FUNCTION REGULATING AGENT, AND FOOD OR BEVERAGE PRODUCT CONTAINING SAME
#214Peptides and combination of peptides for use in immunotherapy against various tumors
#215Peptides and combination of peptides for use in immunotherapy against various tumors
#216Metal compound having phase transformation and method of preparing the same
#217Peptides and combination of peptides for use in immunotherapy against various tumors
#218METHODS AND KITS FOR PREPARING PATHOGEN-INACTIVATED WHOLE BLOOD
#219Compositions and methods for treating or limiting development of age-related macular degeneration
#220Peptides and combination of peptides for use in immunotherapy against various tumors
#221Peptides and combination of peptides for use in immunotherapy against various tumors
#222Peptides and combination of peptides for use in immunotherapy against various tumors
#223PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#224Peptides and combination of peptides for use in immunotherapy against various tumors
#225Peptides and combination of peptides for use in immunotherapy against various tumors
#226Methods and compositions for the prevention or treatment of Barth syndrome
#227Peptides and combination of peptides for use in immunotherapy against various tumors
#228Peptides and combination of peptides for use in immunotherapy against various tumors
#229Peptides and combination of peptides for use in immunotherapy against various tumors
#230Peptides and combination of peptides for use in immunotherapy against various tumors
#231Peptides and combination of peptides for use in immunotherapy against various tumors
#232Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#233COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE CONTRACTURES
#234Bifunctional compositions for the treatment of cancer
#235METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#236COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN
#237Pharmaceutical combinations for treating cancer
#238SYSTEMS FOR TARGETED TISSUE BIOSEALING OR REPAIR
#239Nano-lipid carrier for encapsulation of bioactive material, and method for producing same
#240Liposomal compositions and methods of use
#241TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS
#242COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS
#24317beta-heterocyclyl-digitalis like compounds for the treatment of heart failure
#244COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INSULIN RESISTANCE AND METABOLIC CONDITIONS
#245Use of Immunomodulators to Control Infection and Stimulate Healing in Normal and Diabetic Wounds
#246LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#247PEPTIDES FOR TREATING MUCOSA
#248COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INFLAMMATION
#249Nutritional Supplements Containing A Peptide Component And Uses Thereof
#250Riluzole prodrugs and their use
#251PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#252Compositions and methods for treating glioblastoma
#253Riluzole prodrugs and their use
#254Cosmetic compositions
#255Compositions and methods for invasive and non-invasive procedural skincare
#256MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#257Toll-like receptor 4 (TLR4) inhibitors and use thereof
#258Peptides and combination of peptides for use in immunotherapy against various tumors
#259Peptides and combination of peptides for use in immunotherapy against various tumors
#260COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
#261Peptides and combination of peptides for use in immunotherapy against various tumors
#262Methods for cancer therapy
#263Affinity illudofulvene conjugates
#264CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#265CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#266Methods and compositions for preventing or treating ophthalmic conditions
#267Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#268USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS
#269Bone repair material and preparation method thereof, and biological composite scaffold
#270IMMUNOPROTEASOME INHIBITORS AND IMMUNOSUPPRESSIVE AGENT IN THE TREATMENT OF AUTOIMMUNE DISORDERS
#271HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF
#272Compositions and methods for enhanced aquatic farming and aquarium fish husbandry
#273Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate
#274ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES
#275BIOACTIVE GREEN-LIPPED MUSSEL EXTRACTS AND USES THEREOF
#276ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF
#277ANTIVIRAL COMPOUNDS
#278Amino acid compositions and methods of manufacturing the compositions
#279Methods for reducing CD36 expression
#280METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#281Aromatic-cationic peptides and uses of same
#282Compositions and methods for treating vaginal dryness
#283METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#284Peptides and related compositions and methods
#285Methods for prevention and treatment of acute renal injury
#286METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#287Solid Pharmaceutical Compositions for Treating HCV
#288Peptidomimetics for the treatment of coronavirus and picornavirus infections
#289Peptide therapies for reduction of macular thickening
#290TOPICAL COMPOSITIONS
#291Histatins and method of use thereof
#292PEPTIDE COMPOSITIONS AND RELATED METHODS
#293Wearable phototherapy apparatus with anti-viral and other effects
#294Peptide capable of improving cognitive function
#295Cholecystokinin B receptor targeting for imaging and therapy
#296USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION
#297COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES
#298Methods and compositions for the prevention and treatment of disease
#299LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#300CRYSTAL OF REDUCED GLUTATHIONE AND METHOD FOR PRODUCING SAME